Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 10/2023

Open Access 29-08-2023 | Heart Failure | Heart Failure (HJ Eisen, Section Editor)

The Effect of EECP on Ischemic Heart Failure: a Systematic Review

Authors: Ling Xu, Ming Cui, Wei Zhao

Published in: Current Cardiology Reports | Issue 10/2023

Login to get access

Abstract

Purpose of Review

Heart failure is a serious global health problem, and coronary artery disease is one of the main causes. At present, the treatment options for ischemic heart failure (IHF) are limited. This article mainly aims to explore the evidence of enhanced external counterpulsation (EECP) as a non-invasive cardiac rehabilitation method in patients with IHF and to make a preliminary exploration of its mechanisms.

Recent Findings

According to the existing evidence, the standard course of EECP is safe in patients with IHF and can significantly improve the quality of life of these patients. The effect of EECP on systolic function is still unclear, while EECP has a significant improvement effect on cardiac diastolic function. At the same time, this treatment can reduce the re-hospitalization rate and emergency visit rate of patients within 6 months. In terms of mechanisms, in addition to the immediate hemodynamic effect, existing evidence mostly suggests that its improvement of cardiac function may come from its upregulation of shear stress to improve myocardial perfusion.

Summary

EECP is safe to use in patients with stable ischemic heart failure, and it can improve the performance status of patients and may be beneficial to cardiac function and reduce the short-term re-hospitalization rate.
Literature
1.
Chinese College of Cardiovascular Physicians, Chinese Heart Failure Center Alliance. Expert Consensus on Decision-making Pathway for Quadruple Pharmacotherapy Management of Chronic Heart Failure. Chin Circ J. 2022;37:769–81.
2.
Liyuan M, ZengW W, Jing F, Shengshou H. Summary of the China cardiovascular health and disease report 2021. Chin J Intervent Cardiol. 2022;30(7):481–95.
3.
Guifu W, Zhimin D, Chengheng H, et al. Enhanced External Counterpulsation-Theory and Practice, 1st edit. People’s Medical Publishing House; 2012.
4.
Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003;107(1):149–58.CrossRefPubMed
5.
Task Force M, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.CrossRef
6.
Cardiovascular Group, Geriatrics Branch, Chinese Medical Association. Expert consensus on the clinical application of external counterpulsation in elderly people. Chin J Geriatr. 2019;38(9):953–61.
7.
Sharma U, Ramsey HK, Tak T. The role of enhanced external counter pulsation therapy in clinical practice. Clin Med Res. 2013;1(4):226–32.CrossRef
8.
William E, Lawsom, Marc AS, et al. Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation. Journal of Cardiac Failure. 2005;11(1):61–6.
9.
Soran O, Kennard ED, Kfoury AG, et al. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (Report from the International EECP Patient Registry). Am J Cardiol. 2006;97:17–20.
10.
Abbottsmith CW, Chung ES, Varricchione T, et al. Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail. 2006;12(6):307–11.
11.
Tecson KM, Silver MA, Brune SD, et al. Impact of enhanced external counterpulsation on heart failure rehospitalization in patients with ischemic cardiomyopathy. Am J Cardiol. 2016;117:901–5.CrossRefPubMed
12.
Manchanda A, Soran O. Enhanced external counterpulsation and future directions step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol. 2007;50:1523–31.CrossRefPubMed
13.
Abdelwahab AA, Elsaied AM. Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting? The Egyptian Heart Journal. 2018;70:119–23.CrossRefPubMedPubMedCentral
14.
Bonetti PO, Holmes DR, Lerman A, et al. Enhanced external counterpulsation for ischemic heart disease what’s behind the curtain? J Am Coll Cardiol. 2003;41:1918–25.CrossRefPubMed
15.
Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J South Afr. 2007;18:154–6.
16.
Esmaeilzadeh M, Khaledifar A, Maleki M, et al. Evaluation of left ventricular systolic and diastolic regional function after enhanced external counterpulsation therapy using strain rate imaging. Eur J Echocardiogr. 2009;10(1):120–6.CrossRefPubMed
17.
Fariba E, Naser A, Babak M, et al. Therapeutic effects of enhanced external counterpulsation (EECP) on clinical symptoms, echocardiographic measurements, perfusion scan parameters and exercise tolerance test in coronary artery disease patients with refractory angina. Int J Med Sci Public Health. 2013;2(2):187–95.CrossRef
18.
Ramasamy S, Sushma N, Chokkalingam M, et al. Effect of enhanced external counterpulsation treatment on aortic blood pressure, arterial stiffness and ejection fraction in patients with coronary artery disease. JCDR. 2016;10(10):30–4.
19.
Eftekhari A, May O. The immediate hemodynamic effects of enhanced external counterpulsation on the left ventricular function. Scandinavian Cardiovascular Journal. 2012;46(2):81–6.CrossRefPubMed
20.
Urano H, Ikeda H, Ueno T, et al. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93–9.CrossRefPubMed
21.
Zhang Y, He XH, Liu DH, et al. Enhanced external counterpulsation attenuates atherosclerosis progression through modulation of proinflammatory signal pathway. Arterioscler Thromb Vasc Biol.2010;30(4):773–80.
22.
Alvaro NG, Randy WB. Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans. Hypertens Res. 2013;36(4):297–305.CrossRef
23.
• Xu L, Chen X, Cui M, et al. The improvement of the shear stress and oscillatory shear index of coronary arteries during enhanced external counterpulsation in patients with coronary heart disease. PLoS ONE. 2020;15(3):e0230144. This study used computational fluid dynamics to simulate the hemodynamic changes of the coronary tree before and during EECP treatment and found that EECP can significantly increase the shear stress and improve the local blood flow state, laying the foundation for the exploration of the mechanism of EECP.
24.
Beck DT, Casey DP, Jeffrey S, et al. Enhanced external counterpulsation reduces indices of central blood pressure and myocardial oxygen demand in patients with left ventricular dysfunction. Clin Exp Pharmacol Physiol. 2015;42(4):315–20.CrossRefPubMedPubMedCentral
25.
Jing Z, Yi SL, Shu C. Shear stress-initiated signaling and its regulation of endothelial function. Arterioscler Thromb Vasc Biol. 2014;34(10):2191–8.
26.
Frank G, Yuki K, Peter B, et al. Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications. Eur Heart J. 2019;40(41):1–17.
27.
Kimiko Y, Tomono T, Takayuki A, et al. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol. 2003;95(5):2081–8.
28.
Zeng LF, Xiao QZ, Andriana M, et al. Shear stress-induced stem cell differentiation toward endothelial cells is regulated by HDAC-P53-P21 pathways. 14th IVBM Abstracts. 2012;E52.
29.
Chiu JJ, Lee PL, Chen CN, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-α in endothelial cells. Arterioscler Thromb Vasc Biol. 2004; 24(1):73–9.
30.
Lee DY, Chiu JJ. Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium. J Biomed Sci; 2019;26(1):56–73.
31.
Brian SC, Zhong DS, Zhao WD, et al. Shear stress regulates occludin and VEGF expression in porcine arterial endothelial cells. J Surg Res. 2002;102(1):13–21.
32.
Joseph WW, Sarah D, Helen MM, et al. Shear stress regulated gene expression and angiogenesis in vascular endothelium. Microcirculation. 2014;21(4):290–300.
33.
Sven C, Nigussie MD, Margret H, et al. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett. 2007;581(4):673–80.CrossRef
34.
Madhulika D, Elke B, Beate F, et al. Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells. Cardiovasc Res. 2008;77(1):160–8.
35.
Sarah LT, Huang RP, Tomsen Nicholas T, et al. Laminar shear inhibits tubule formation and migration of endothelial cells by an angiopoietin-2–dependent mechanism. Arterioscler Thromb Vasc Biol. 2007;27(10):2150–6.CrossRef
36.
Syotaro O, Haruchika M, Tomoko S, et al. Fluid shear stress induces differentiation of circulating phenotype endothelial progenitor cells. Am J Physiol Cell Physiol. 2012;303(6):595–606.CrossRef
37.
Zhen Y, Xia WH, Zhang YY, et al.Shear stress-induced activation of Tie2-dependent signaling pathway enhances reendothelialization capacity of early endothelial progenitor cells. J Mol Cell Cardiol. 2012;52(5):1155–63.
38.
Sarah LT. Role of shear stress in angiopoietin-2 dependent neovascularization: implications in occlusive vascular disease and atherosclerosis (Dissertation). Georgia Institute of Technology: Emory University; 2008.
39.
Buschmann EE, Utz W, Pagonas N, et al. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial). Eur J Clin Invest. 2009; 39 (10):866–75.
40.
• Cui NQ, Sakurai T, Kamiyoshi A, et al. Adrenomedullin-RAMP2 and -RAMP3 systems regulate cardiac homeostasis during cardiovascular stress. Endocrinology. 2021;162(3):1–20. This study proves that ADM plays an important role in maintaining the aerobic oxidation capacity of mitochondria, thereby further ensuring the cardiac systolic function. Combined with the previous research results of our research group, it provides clues for other potential mechanisms of EECP.CrossRef
41.
Du YM, Tang M, Liu CJ, et al. Inhibitory effect of adrenomedullin on L-type calcium currents in guinea-pig ventricular myocytes. Sheng Li Xue Bao; 2002;54(6):479–84.
Metadata
Title
The Effect of EECP on Ischemic Heart Failure: a Systematic Review
Authors
Ling Xu
Ming Cui
Wei Zhao
Publication date
29-08-2023
Publisher
Springer US
Keyword
Heart Failure
Published in
Current Cardiology Reports / Issue 10/2023
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-023-01943-1

Other articles of this Issue 10/2023

Current Cardiology Reports 10/2023 Go to the issue

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Insomnia and Cardiovascular Health: Exploring the Link Between Sleep Disorders and Cardiac Arrhythmias

Management of Acute Coronary Syndromes (H Jneid, Section Editor)

Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men

Ischemic Heart Disease (D Mukherjee, Section Editor)

Sodium Homeostasis and Hypertension

Valvular Heart Disease (TL Kiefer, Section Editor)

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation

Valvular Heart Disease (TL Kiefer, Section Editor)

Advances in aortic regurgitation

Pericardial Disease (AL Klein and CL Jellis, Section Editors)

Pericarditis Management in Individuals Contemplating Pregnancy, Currently Pregnant, or Breastfeeding